Sponsor Dossier
Hameln Pharma
Sponsor Dossier for Hameln Pharma. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ALFENTANIL-HAMELN
- Brand: DOBUTAMINE-HAMELN
- Brand: EPHEDRINE-HAMELN
- Brand: FENTANYL-HAMELN
- Brand: HYDROMORPHONE-HAMELN
- Brand: HYDROMORPHONE-HAMELN-HP
- Brand: OXYCODONE-HAMELN
- Brand: ROCURONIUM-HAMELN
About
Hameln Pharma is an Australian Private Company with ABN 69638348580, registered in Victoria. The entity is active and registered for GST from 8 January 2020.
Portfolio
Hameln Pharma has 8 brands on the ARTG, of which 7 are indexable. Seven brands have Product Information on file. The portfolio includes no PBS-listed brands, no brands with PBAC outcomes on record, and no brands with AusPARs on record.
Therapeutic focus
— Pain & Anaesthesia: 7 brands — Cardiology: 1 brand
PBS footprint
Hameln Pharma has no brands on the PBS.